CMS Coverage, FDA Review Process Overlap Studied By HHS Secretary Panel
This article was originally published in The Gray Sheet
Executive Summary
The HHS Secretary's Advisory Committee on Regulatory Reform will consider proposals to coordinate CMS' coverage analysis process with FDA's evaluation of new technologies to prevent duplicative requirements